Evidence map›Paper›PMID 31412844›Full record

ArticleBMC complementary and alternative medicine2019

Xiaoyaosan exerts antidepressant-like effects by regulating the functions of astrocytes and EAATs in the prefrontal cortex of mice.

Yan Liu, Xiu-Fang Ding, Xin-Xing Wang, Xiao-Juan Zou, Xiao-Juan Li, Yue-Yun Liu, Jie Li, Xiu-Yun Qian, Jia-Xu Chen

RetractedOpen access · goldAbstract readRetracted Publication
In one paragraph

Article in BMC complementary and alternative medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 22 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 1 pooled it
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 1 synthesis or guideline pooled it, 37 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Yan LiuSchool of Pre-clinical Medicine, Hubei University of Chinese Medicine, Wuhan, 430065, China.
Xiu-Fang DingSchool of Traditional Chinese medicine, Beijing University of Chinese Medicine, No. 11 North Third Ring Road Chaoyang District, Beijing, 100029, China.
Xin-Xing WangSchool of Pre-clinical Medicine, Henan University of Chinese Medicine, Zhengzhou, 450046, China.
Xiao-Juan ZouSchool of Pre-clinical Medicine, Hubei University of Chinese Medicine, Wuhan, 430065, China.
Xiao-Juan LiSchool of Pre-clinical Medicine, Hubei University of Chinese Medicine, Wuhan, 430065, China.
Yue-Yun LiuSchool of Traditional Chinese medicine, Beijing University of Chinese Medicine, No. 11 North Third Ring Road Chaoyang District, Beijing, 100029, China.
Jie LiSchool of Pre-clinical Medicine, Henan University of Chinese Medicine, Zhengzhou, 450046, China.
Xiu-Yun QianSchool of Pre-clinical Medicine, Henan University of Chinese Medicine, Zhengzhou, 450046, China.
Jia-Xu ChenSchool of Pre-clinical Medicine, Hubei University of Chinese Medicine, Wuhan, 430065, China. chenjiaxu@hotmail.com.
Beijing University of Chinese Medicine · CNFirst Affiliated Hospital of Henan University · CNHubei University of Chinese Medicine · CNShandong University of Traditional Chinese Medicine · CN

Funding

Beijing Natural Sciences Foundation 7152093National Natural Science Foundation of China 81473597National Natural Science Foundation of China 81630104
6 · The paper itself

Abstract

backgroundMounting evidence indicates that the cerebral cortex is an important physiological system of emotional activity, and its dysfunction may be the main cause of stress. Glutamate is the primary excitatory neurotransmitter in the central nervous system (CNS), which initiates rapid signal transmission in the synapse before its reuptake into the surrounding glia, specifically astrocytes (ASTs). The astrocytic excitatory amino acid transporters 1 (EAAT1) and 2 (EAAT2) are the major transporters that take up synaptic glutamate to maintain optimal extracellular glutamic levels, thus preventing accumulation in the synaptic cleft and ensuing excitotoxicity. Growing evidence has shown that excitotoxicity is associated with depression. Therefore, we hypothesized that the underlying antidepressant-like mechanism of Xiaoyaosan (XYS), a Chinese herbal formula, may be related to the regulation of astrocytic EAATs. Therefore, we studied the antidepressant mechanism of XYS on the basis of EAAT dysfunction in ASTs.

methodsEighty adult C57BL/6 J mice were randomly divided into 4 groups: a control group, a chronic unpredictable mild stress (CUMS) group, a Xiaoyaosan (XYS) treatment group and a fluoxetine hydrochloride (Flu) treatment group. Except for the control group, mice in the other groups all received chronic unpredictable mild stress for 21 days. Mice in the control and CUMS groups received gavage administration with 0.5 mL of normal saline (NS) for 21 days, and mice in the XYS and Flu treatment groups were administered dosages of 0.25 g/kg/d and 2.6 mg/kg/d by gavage. The effects of XYS on the depressive-like behavioral tests, including the open field test (OFT), forced swimming test (FST) and sucrose preference test (SPT), were examined. The glutamate (Glu) concentrations of the prefrontal cortex (PFC) were detected with colorimetry. The morphology of neurons in the PFC was observed by Nissl staining. The expression of glial fibrillary acidic protein (GFAP), NeuN, EAAT1 and EAAT2 proteins in the PFC of mice was detected by using Western blotting and immunohistochemistry. Quantitative real-time PCR (qPCR) was used to detect the expression of the GFAP, NeuN, EAAT1 and EAAT2 genes in the PFC of mice.

resultsThe results of behavioral tests showed that CUMS-induced mice exhibited depressive-like behavior, which could be improved in some tests with XYS and Flu treatment. Immunohistochemistry and Western blot analysis showed that the protein levels of GFAP, NeuN, EAAT1 and EAAT2 in the PFC of CUMS mice were significantly lower than those in the control group, and these changes could be reversed by XYS and Flu. The results of qPCR analysis showed that the expression of GFAP, NeuN, EAAT1 and EAAT2 mRNAs in the PFC of CUMS mice was not significantly changed, with the exception of EAAT2, compared with that of the control group, while the expression of the above mRNAs was significantly higher in the XYS and Flu groups than that in the CUMS group.

conclusionXYS may exert antidepressant-like effects by improving the functions of AST and EAATs and attenuating glutamate-induced neuronal damage in the frontal cortex.

Indexed as

AnimalsAntidepressive AgentsAstrocytesBehavior, AnimalDepressionDisease Models, AnimalDrugs, Chinese HerbalExcitatory Amino Acid Transporter 1Excitatory Amino Acid Transporter 2Glial Fibrillary Acidic ProteinGlutamic AcidHumansMaleMiceMice, Inbred C57BLPrefrontal CortexAntidepressive AgentsDrugs, Chinese HerbalExcitatory Amino Acid Transporter 1Excitatory Amino Acid Transporter 2Glial Fibrillary Acidic ProteinGlutamic AcidxiaoyaosanASTChronic unpredictable mild stressDepressionEAATsXiaoyaosan

Identifiers

PMID31412844
PMCPMC6694586
OpenAlexW2968241016

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.